✦ LIBER ✦

Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen

✍ Scribed by Christian Saure; Thomas Schroeder; Fabian Zohren; Anke Groten; Ingmar Bruns; Akos Czibere; Lars Galonska; Mustafa Kondakci; Christian Weigelt; Roland Fenk; Ulrich Germing; Rainer Haas; Guido Kobbe

Book ID: 116282762
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 305 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermediate intensity conditioning regi

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia

✍ Jens Marcus Chemnitz; Marie von Lilienfeld-Toal; Udo Holtick; Sebastian Theurich 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 166 KB

Allogeneic stem cell transplantation aft

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

✍ N. Kröger; M. Bornhäuser; G. Ehninger; R. Schwerdtfeger; H. Biersack; H. G. Saye 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 201 KB

Prognostic factors for patients with acu

Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation

✍ Thorsten Graef; Matthias Vaupel; Roland Fenk; Leilani Ruf; Fabian Zohren; Ulrich 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract In this uni‐centre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__ = 88) and myelodysplastic syndrome (MDS) (__n__ = 32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)

Reduced-toxicity conditioning with treos

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)

✍ Kröger, N; Shimoni, A; Zabelina, T; Schieder, H; Panse, J; Ayuk, F; Wolschke, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

High antileukemic efficacy of an interme

High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission

✍ Schmid, C; Schleuning, M; Hentrich, M; Markl, G E; Gerbitz, A; Tischer, J; Ledde 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

Cytoreductive treatment with clofarabine

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

✍ Stefanie Buchholz; Elke Dammann; Michael Stadler; Juergen Krauter; Gernot Beutel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB